Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins

Targeting aberrant epigenetic programs that drive tumorigenesis is a promising approach to cancer therapy. DNA-encoded library (DEL) screening is a core platform technology increasingly used to identify drugs that bind to protein targets. Here, we use DEL screening against bromodomain and extra-term...

Full description

Bibliographic Details
Main Authors: Seoyeon Jeong, Hwa-Ryeon Kim, June-Ha Shin, Min-Hee Son, In-Hyun Lee, Jae-Seok Roe
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253123001099
_version_ 1797831790768947200
author Seoyeon Jeong
Hwa-Ryeon Kim
June-Ha Shin
Min-Hee Son
In-Hyun Lee
Jae-Seok Roe
author_facet Seoyeon Jeong
Hwa-Ryeon Kim
June-Ha Shin
Min-Hee Son
In-Hyun Lee
Jae-Seok Roe
author_sort Seoyeon Jeong
collection DOAJ
description Targeting aberrant epigenetic programs that drive tumorigenesis is a promising approach to cancer therapy. DNA-encoded library (DEL) screening is a core platform technology increasingly used to identify drugs that bind to protein targets. Here, we use DEL screening against bromodomain and extra-terminal motif (BET) proteins to identify inhibitors with new chemotypes, and successfully identified BBC1115 as a selective BET inhibitor. While BBC1115 does not structurally resemble OTX-015, a clinically active pan-BET inhibitor, our intensive biological characterization revealed that BBC1115 binds to BET proteins, including BRD4, and suppresses aberrant cell fate programs. Phenotypically, BBC1115-mediated BET inhibition impaired proliferation in acute myeloid leukemia, pancreatic, colorectal, and ovarian cancer cells in vitro. Moreover, intravenous administration of BBC1115 inhibited subcutaneous tumor xenograft growth with minimal toxicity and favorable pharmacokinetic properties in vivo. Since epigenetic regulations are ubiquitously distributed across normal and malignant cells, it will be critical to evaluate if BBC1115 affects normal cell function. Nonetheless, our study shows integrating DEL-based small-molecule compound screening and multi-step biological validation represents a reliable strategy to discover new chemotypes with selectivity, efficacy, and safety profiles for targeting proteins involved in epigenetic regulation in human malignancies.
first_indexed 2024-04-09T13:57:21Z
format Article
id doaj.art-fc2d400b546f4c0c8eba57b2ad04436d
institution Directory Open Access Journal
issn 2162-2531
language English
last_indexed 2024-04-09T13:57:21Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Molecular Therapy: Nucleic Acids
spelling doaj.art-fc2d400b546f4c0c8eba57b2ad04436d2023-05-08T04:09:17ZengElsevierMolecular Therapy: Nucleic Acids2162-25312023-06-0132637649Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteinsSeoyeon Jeong0Hwa-Ryeon Kim1June-Ha Shin2Min-Hee Son3In-Hyun Lee4Jae-Seok Roe5Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, KoreaDepartment of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, KoreaDepartment of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, KoreaBenobio Co., Ltd., Seoul, KoreaBenobio Co., Ltd., Seoul, KoreaDepartment of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea; Corresponding author: Jae-Seok Roe, PhD, Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.Targeting aberrant epigenetic programs that drive tumorigenesis is a promising approach to cancer therapy. DNA-encoded library (DEL) screening is a core platform technology increasingly used to identify drugs that bind to protein targets. Here, we use DEL screening against bromodomain and extra-terminal motif (BET) proteins to identify inhibitors with new chemotypes, and successfully identified BBC1115 as a selective BET inhibitor. While BBC1115 does not structurally resemble OTX-015, a clinically active pan-BET inhibitor, our intensive biological characterization revealed that BBC1115 binds to BET proteins, including BRD4, and suppresses aberrant cell fate programs. Phenotypically, BBC1115-mediated BET inhibition impaired proliferation in acute myeloid leukemia, pancreatic, colorectal, and ovarian cancer cells in vitro. Moreover, intravenous administration of BBC1115 inhibited subcutaneous tumor xenograft growth with minimal toxicity and favorable pharmacokinetic properties in vivo. Since epigenetic regulations are ubiquitously distributed across normal and malignant cells, it will be critical to evaluate if BBC1115 affects normal cell function. Nonetheless, our study shows integrating DEL-based small-molecule compound screening and multi-step biological validation represents a reliable strategy to discover new chemotypes with selectivity, efficacy, and safety profiles for targeting proteins involved in epigenetic regulation in human malignancies.http://www.sciencedirect.com/science/article/pii/S2162253123001099MT: BioinformaticsDNA-encoded libraryBET proteinshistone acetylationMYCepigenetic therapy
spellingShingle Seoyeon Jeong
Hwa-Ryeon Kim
June-Ha Shin
Min-Hee Son
In-Hyun Lee
Jae-Seok Roe
Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins
Molecular Therapy: Nucleic Acids
MT: Bioinformatics
DNA-encoded library
BET proteins
histone acetylation
MYC
epigenetic therapy
title Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins
title_full Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins
title_fullStr Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins
title_full_unstemmed Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins
title_short Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins
title_sort streamlined dna encoded small molecule library screening and validation for the discovery of novel chemotypes targeting bet proteins
topic MT: Bioinformatics
DNA-encoded library
BET proteins
histone acetylation
MYC
epigenetic therapy
url http://www.sciencedirect.com/science/article/pii/S2162253123001099
work_keys_str_mv AT seoyeonjeong streamlineddnaencodedsmallmoleculelibraryscreeningandvalidationforthediscoveryofnovelchemotypestargetingbetproteins
AT hwaryeonkim streamlineddnaencodedsmallmoleculelibraryscreeningandvalidationforthediscoveryofnovelchemotypestargetingbetproteins
AT junehashin streamlineddnaencodedsmallmoleculelibraryscreeningandvalidationforthediscoveryofnovelchemotypestargetingbetproteins
AT minheeson streamlineddnaencodedsmallmoleculelibraryscreeningandvalidationforthediscoveryofnovelchemotypestargetingbetproteins
AT inhyunlee streamlineddnaencodedsmallmoleculelibraryscreeningandvalidationforthediscoveryofnovelchemotypestargetingbetproteins
AT jaeseokroe streamlineddnaencodedsmallmoleculelibraryscreeningandvalidationforthediscoveryofnovelchemotypestargetingbetproteins